Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant Enterococcus in the health care setting

Journal of Clinical Microbiology

Volumn 54, Issue 10, 2016, Pages 2436-2447

  Faron, Matthew L ^a   Ledeboer, Nathan A ^a,b   Buchan, Blake W ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Diagnostic Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; METRONIDAZOLE; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; COST BENEFIT ANALYSIS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS RAFFINOSUS; HEALTHCARE ASSOCIATED INFECTION; INFECTION CONTROL; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PEPTOCLOSTRIDIUM DIFFICILE; PREVALENCE; PRIORITY JOURNAL; SCREENING; SHORT SURVEY; VANCOMYCIN RESISTANT ENTEROCOCCUS; CROSS INFECTION; DISEASE TRANSMISSION; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH CARE FACILITY; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGY; PREVENTION AND CONTROL; PROCEDURES;

CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH FACILITIES; HUMANS; INFECTION CONTROL; MASS SCREENING; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84991208719     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00211-16     Document Type: Short Survey

References (79)

1. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Witte W, Friedrich AW. 2014. Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill 19:pii=20860. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20860.
2. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S, National Healthcare Safety Network (NHSN) Team and Participating NHSN Families. 2013. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34:1-14. http://dx.doi.org/10.1086/668770.
3. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. 2007. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 28:196-203.
4. Wang JS, Muzevich K, Edmond MB, Bearman G, Stevens MP. 2014. Central nervous system infections due to vancomycin-resistant enterococci: case series and review of the literature. Int J Infect Dis 25:26-31. http://dx.doi.org/10.1016/j.ijid.2014.01.009.
5. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. 2005. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41:327-333. http://dx.doi.org/10.1086/430909.
6. Leclercq R, Derlot E, Duval J, Courvalin P. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 319:157-161. http://dx.doi.org/10.1056/NEJM198807213190307.
7. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G, Faur Y, Eisner W, Warren S, Kreiswirth B. 1993. Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76-79. http://dx.doi.org/10.1016/0140-6736(93)91285-T.
8. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
9. Stiefel U, Nerandzic MM, Pultz MJ, Donskey CJ. 2014. Gastrointestinal colonization with a cephalosporinase-producing Bacteroides species preserves colonization resistance against vancomycin-resistant Enterococcus and Clostridium difficile in cephalosporin-treated mice. Antimicrob Agents Chemother 58:4535-4542. http://dx.doi.org/10.1128/AAC.02782-14.
10. Leavis HL, Willems RJ, van Wamel WJ, Schuren FH, Caspers MP, Bonten MJ. 2007. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog 3:e7. http://dx.doi.org/10.1371/journal.ppat.0030007.
11. O'Driscoll T, Crank CW. 2015. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 8:217-230.
12. Cetinkaya Y, Falk P, Mayhall CG. 2000. Vancomycin-resistant enterococci. Clin Microbiol Rev 13:686-707. http://dx.doi.org/10.1128/CMR.13.4.686-707.2000.
13. Aslangul E, Massias L, Meulemans A, Chau F, Andremont A, Courvalin P, Fantin B, Ruimy R. 2006. Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis. Antimicrob Agents Chemother 50:3615-3621. http://dx.doi.org/10.1128/AAC.00390-06.
14. Abat C, Raoult D, Rolain JM. 2016. Low level of resistance in enterococci isolated in four hospitals, Marseille, France. Microb Drug Resist 22:218-222.
15. Dadfarma N, Imani Fooladi AA, Oskoui M, Mahmoodzadeh Hosseini H. 2013. High level of gentamicin resistance (HLGR) among Enterococcus strains isolated from clinical specimens. J Infect Public Health 6:202-208. http://dx.doi.org/10.1016/j.jiph.2013.01.001.
16. Parameswarappa J, Basavaraj VP, Basavaraj CM. 2013. Isolation, identification, and antibiogram of enterococci isolated from patients with urinary tract infection. Ann Afr Med 12:176-181. http://dx.doi.org/10.4103/1596-3519.117629.
17. Moellering RC, Jr, Wennersten C, Weinberg AN. 1971. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. J Lab Clin Med 77:821-828.
18. Williamson R, Calderwood SB, Moellering RC, Jr, Tomasz A. 1983. Studies on the mechanism of intrinsic resistance to beta-lactam antibiotics in group D streptococci. J Gen Microbiol 129:813-822.
19. Hollenbeck BL, Rice LB. 2012. Intrinsic and acquired resistance mechanisms in Enterococcus. Virulence 3:421-433. http://dx.doi.org/10.4161/viru.21282.
20. Fontana R, Grossato A, Rossi L, Cheng YR, Satta G. 1985. Transition from resistance to hypersusceptibility to beta-lactam antibiotics associated with loss of a low-affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillin. Antimicrob Agents Chemother 28:678-683. http://dx.doi.org/10.1128/AAC.28.5.678.
21. Duez C, Zorzi W, Sapunaric F, Amoroso A, Thamm I, Coyette J. 2001. The penicillin resistance of Enterococcus faecalis JH2-2r results from an overproduction of the low-affinity penicillin-binding protein PBP4 and does not involve a psr-like gene. Microbiology 147:2561-2569. http://dx.doi.org/10.1099/00221287-147-9-2561.
22. Murray BE. 1997. Vancomycin-resistant enterococci. Am J Med 102: 284-293. http://dx.doi.org/10.1016/S0002-9343(99)80270-8.
23. Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A. 2010. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. J Hosp Infect 75:225-227. http://dx.doi.org/10.1016/j.jhin.2009.12.007.
24. Fernández-Hidalgo N, Almirante B, Gavalda J, Gurgui M, Pena C, de Alarcon A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, Lopez-Medrano F, Plata A, Lopez J, Hidalgo-Tenorio C, Galvez J, Saez C, Lomas JM, Falcone M, de la Torre J, Martinez-Lacasa X, Pahissa A. 2013. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 56:1261-1268. http://dx.doi.org/10.1093/cid/cit052.
25. Leone S, Noviello S, Esposito S. 2016. Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci. Infection 44:273-281.
26. Walsh CT, Fisher SL, Park IS, Prahalad M, Wu Z. 1996. Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem Biol 3:21-28.
27. Lai MH, Kirsch DR. 1996. Induction signals for vancomycin resistance encoded by the vanA gene cluster in Enterococcus faecium. Antimicrob Agents Chemother 40:1645-1648.
28. al-Obeid S, Billot-Klein D, van Heijenoort J, Collatz E, Gutmann L. 1992. Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain vancomycin-beta-lactam synergy in low-level vancomycin-resistant Enterococcus faecium D366. FEMS Microbiol Lett 70:79-84.
29. Arthur M, Depardieu F, Molinas C, Reynolds P, Courvalin P. 1995. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 154:87-92. http://dx.doi.org/10.1016/0378-1119(94)00851-I.
30. Coombs GW, Pearson JC, Daley DA, Le T, Robinson OJ, Gottlieb T, Howden BP, Johnson PD, Bennett CM, Stinear TP, Turnidge JD, Australian Group on Antimicrobial Resistance. 2014. Molecular epidemiology of enterococcal bacteremia in Australia. J Clin Microbiol 52:897-905. http://dx.doi.org/10.1128/JCM.03286-13.
31. Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A, European VRE Study Group. 2000. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 19:816-822. http://dx.doi.org/10.1007/s100960000390.
32. Arthur M, Depardieu F, Reynolds P, Courvalin P. 1996. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol Microbiol 21:33-44. http://dx.doi.org/10.1046/j.1365-2958.1996.00617.x.
33. de Niederhäusern S, Bondi M, Messi P, Iseppi R, Sabia C, Manicardi G, Anacarso I. 2011. Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus. Curr Microbiol 62:1363-1367. http://dx.doi.org/10.1007/s00284-011-9868-6.
34. Centers for Disease Control and Prevention. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep 51:565-567.
35. Walters MS, Eggers P, Albrecht V, Travis T, Lonsway D, Hovan G, Taylor D, Rasheed K, Limbago B, Kallen A. 2015. Vancomycin-Resistant Staphylococcus aureus-Delaware, 2015. MMWR Morb Mortal Wkly Rep 64:1056. http://dx.doi.org/10.15585/mmwr.mm6437a6.
36. Werner G, Freitas AR, Coque TM, Sollid JE, Lester C, Hammerum AM, Garcia-Migura L, Jensen LB, Francia MV, Witte W, Willems RJ, Sundsfjord A. 2011. Host range of enterococcal vanA plasmids among Grampositive intestinal bacteria. J Antimicrob Chemother 66:273-282. http://dx.doi.org/10.1093/jac/dkq455.
37. Orsi GB, Ciorba V. 2013. Vancomycin resistant enterococci healthcare associated infections. Ann Ig 25:485-492.
38. Bonten MJ, Hayden MK, Nathan C, Rice TW, Weinstein RA. 1998. Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis 177:378-382. http://dx.doi.org/10.1086/514196.
39. Ford CD, Lopansri BK, Gazdik MA, Snow GL, Webb BJ, Konopa KL, Petersen FB. 2015. The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation. Transpl Infect Dis 17:688-694. http://dx.doi.org/10.1111/tid.12433.
40. Kramer A, Schwebke I, Kampf G. 2006. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130. http://dx.doi.org/10.1186/1471-2334-6-130.
41. Byers KE, Durbin LJ, Simonton BM, Anglim AM, Adal KA, Farr BM. 1998. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 19:261-264. http://dx.doi.org/10.2307/30142418.
42. Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, Cronin M, Nasraway SA, Golan Y. 2008. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 46:678-685. http://dx.doi.org/10.1086/527394.
43. Kingston L, O'Connell NH, Dunne CP. 2015. Hand hygiene-related clinical trials reported since 2010: a systematic review. J Hosp Infect 92:309-320.
44. Smith PW, Bennett G, Bradley S, Drinka P, Lautenbach E, Marx J, Mody L, Nicolle L, Stevenson K, Society for Healthcare Epidemiology of America (SHEA), Association for Professionals in Infection Control and Epidemiology. 2008. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Am J Infect Control 36:504-535. http://dx.doi.org/10.1016/j.ajic.2008.06.001.
45. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. 2007. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35:S165-193. http://dx.doi.org/10.1016/j.ajic.2007.10.006.
46. Shay DK, Goldmann DA, Jarvis WR. 1995. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. Pediatr Clin North Am 42:703-716. http://dx.doi.org/10.1016/S0031-3955(16)38986-6.
47. Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA. 2006. Reduction in acquisition of vancomycin-resistant Enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 42:1552-1560. http://dx.doi.org/10.1086/503845.
48. Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG, Jr, Smith DL. 2004. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin Infect Dis 38:1108-1115. http://dx.doi.org/10.1086/382886.
49. Bodily M, McMullen KM, Russo AJ, Kittur ND, Hoppe-Bauer J, Warren DK. 2013. Discontinuation of reflex testing of stool samples for vancomycin-resistant enterococci resulted in increased prevalence. Infection Control Hosp Epidemiol 34:838-840. http://dx.doi.org/10.1086/671276.
50. Armeanu E, Bonten MJ. 2005. Control of vancomycin-resistant enterococci: one size fits all? Clin Infect Dis 41:210-216. http://dx.doi.org/10.1086/431206.
51. Price CS, Paule S, Noskin GA, Peterson LR. 2003. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin Infect Dis 37:921-928. http://dx.doi.org/10.1086/377733.
52. Matsushima A, Takakura S, Yamamoto M, Matsumura Y, Shirano M, Nagao M, Ito Y, Iinuma Y, Shimizu T, Fujita N, Ichiyama S. 2012. Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan. Eur J Clin Microbiol Infect Dis 31:1095-1100. http://dx.doi.org/10.1007/s10096-011-1412-x.
53. Fisher D, Pang L, Salmon S, Lin RT, Teo C, Tambyah P, Jureen R, Cook AR, Otter JA. 2016. A successful vancomycin-resistant enterococci reduction bundle at a Singapore hospital. Infection Control Hosp Epidemiol 37:107-109. http://dx.doi.org/10.1017/ice.2015.251.
54. Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, STAR∗ICU Trial Investigators. 2011. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364:1407-1418. http://dx.doi.org/10.1056/NEJMoa1000373.
55. Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, Mundy LM. 2006. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infection Control Hosp Epidemiol 27:1068-1075. http://dx.doi.org/10.1086/507960.
56. Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP. 2001. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infection Control Hosp Epidemiol 22:437-442. http://dx.doi.org/10.1086/501931.
57. Faron ML, Buchan BW, Vismara C, Lacchini C, Bielli A, Gesu G, Liebregts T, van Bree A, Jansz A, Soucy G, Korver J, Ledeboer NA. 2015. Automated scoring of chromogenic media for the detection of MRSA using the WASPLab image analysis software. J Clin Microbiol 54:620-624.
58. Hacek DM, Bednarz P, Noskin GA, Zembower T, Peterson LR. 2001. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program. J Clin Microbiol 39:1152-1154. http://dx.doi.org/10.1128/JCM.39.3.1152-1154.2001.
59. D'Agata EM, Gautam S, Green WK, Tang YW. 2002. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 34:167-172. http://dx.doi.org/10.1086/338234.
60. Robotham JV, Graves N, Cookson BD, Barnett AG, Wilson JA, Edgeworth JD, Batra R, Cuthbertson BH, Cooper BS. 2011. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation. BMJ 343:d5694. http://dx.doi.org/10.1136/bmj.d5694.
61. Das S, Harazin M, Wright MO, Dusich I, Robicsek A, Peterson LR. 2014. Active surveillance and decolonization without isolation is effective in preventing methicillin-resistance Staphylococcus aureus transmission in the psychiatry units. Open Forum Infect Dis 1:ofu067. http://dx.doi.org/10.1093/ofid/ofu067.
62. Suwantarat N, Roberts A, Prestridge J, Seeley R, Speser S, Harmon C, Zhang C, Henciak S, Stamper PD, Ross T, Carroll KC. 2014. Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples. J Clin Microbiol 52:4039-4042. http://dx.doi.org/10.1128/JCM.00151-14.
63. Anderson NW, Buchan BW, Young CL, Newton DW, Brenke C, Lapsley L, Granato PA, Ledeboer NA. 2013. Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Clin Microbiol 51:2758-2760. http://dx.doi.org/10.1128/JCM.00979-13.
64. Peterson JF, Doern CD, Kallstrom G, Riebe KM, Sander T, Dunne WM, Jr, Ledeboer NA. 2010. Evaluation of Spectra VRE, a new chromogenic agar medium designed to screen for vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Clin Microbiol 48:4627-4629. http://dx.doi.org/10.1128/JCM.01676-10.
65. Ledeboer NA, Tibbetts RJ, Dunne WM. 2007. A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Diagn Microbiol Infect Dis 59:477-479. http://dx.doi.org/10.1016/j.diagmicrobio.2007.06.018.
66. Peltroche-Llacsahuanga H, Top J, Weber-Heynemann J, Lutticken R, Haase G. 2009. Comparison of two chromogenic media for selective isolation of vancomycin-resistant enterococci from stool specimens. J Clin Microbiol 47:4113-4116. http://dx.doi.org/10.1128/JCM.00882-09.
67. Devrim F, Gulfidan G, Gozmen S, Demirag B, Oymak Y, Yaman Y, Oruc Y, Yasar N, Apa H, Bayram N, Vergin C, Devrim I. 2015. Comparison of the BD GeneOhm VanR assay and a chromogenic agar-based culture method in screening for vancomycin-resistant enterococci in rectal specimens of pediatric hematology-oncology patients. Turk J Pediatr 57:161-166.
68. Mak A, Miller MA, Chong G, Monczak Y. 2009. Comparison of PCR and culture for screening of vancomycin-resistant enterococci: highly disparate results for vanA and vanB. J Clin Microbiol 47:4136-4137. http://dx.doi.org/10.1128/JCM.01547-09.
69. Babady NE, Gilhuley K, Cianciminio-Bordelon D, Tang YW. 2012. Performance characteristics of the Cepheid Xpert vanA assay for rapid identification of patients at high risk for carriage of vancomycin-resistant enterococci. J Clin Microbiol 50:3659-3663. http://dx.doi.org/10.1128/JCM.01776-12.
70. Gazin M, Lammens C, Goossens H, Malhotra-Kumar S, MOSAR WP2 Study Team. 2012. Evaluation of GeneOhm VanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci. Eur J Clin Microbiol Infect Dis 31:273-276. http://dx.doi.org/10.1007/s10096-011-1306-y.
71. Marner ES, Wolk DM, Carr J, Hewitt C, Dominguez LL, Kovacs T, Johnson DR, Hayden RT. 2011. Diagnostic accuracy of the Cepheid GeneXpert vanA/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Enterococcus from perianal specimens. Diagn Microbiol Infect Dis 69:382-389. http://dx.doi.org/10.1016/j.diagmicrobio.2010.11.005.
72. Sloan LM, Uhl JR, Vetter EA, Schleck CD, Harmsen WS, Manahan J, Thompson RL, Rosenblatt JE, Cockerill FR, III. 2004. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol 42:2636-2643. http://dx.doi.org/10.1128/JCM.42.6.2636-2643.2004.
73. Bourdon N, Berenger R, Lepoultier R, Mouet A, Lesteven C, Borgey F, Fines-Guyon M, Leclercq R, Cattoir V. 2010. Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay. Diagn Microbiol Infect Dis 67:291-293. http://dx.doi.org/10.1016/j.diagmicrobio.2010.02.009.
74. Domingo MC, Huletsky A, Giroux R, Boissinot K, Picard FJ, Lebel P, Ferraro MJ, Bergeron MG. 2005. High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother 49:4784-4786. http://dx.doi.org/10.1128/AAC.49.11.4784-4786.2005.
75. Graham M, Ballard SA, Grabsch EA, Johnson PD, Grayson ML. 2008. High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother 52:1195-1197. http://dx.doi.org/10.1128/AAC.00531-07.
76. Zhou X, Arends JP, Kampinga GA, Ahmad HM, Dijkhuizen B, van Barneveld P, Rossen JW, Friedrich AW. 2014. Evaluation of the Xpert vanA/vanB assay using enriched inoculated broths for direct detection of vanB vancomycin-resistant enterococci. J Clin Microbiol 52:4293-4297. http://dx.doi.org/10.1128/JCM.01125-14.
77. Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM. 2002. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infection Control Hosp Epidemiol 23:429-435. http://dx.doi.org/10.1086/502080.
78. Ostrowsky BE, Trick WE, Sohn AH, Quirk SB, Holt S, Carson LA, Hill BC, Arduino MJ, Kuehnert MJ, Jarvis WR. 2001. Control of vancomycin-resistant Enterococcus in health care facilities in a region. N Engl J Med 344:1427-1433. http://dx.doi.org/10.1056/NEJM200105103441903.
79. Derde LP, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJ, Gniadkowski M, Hryniewicz W, Empel J, Dautzenberg MJ, Annane D, Aragao I, Chalfine A, Dumpis U, Esteves F, Giamarellou H, Muzlovic I, Nardi G, Petrikkos GL, Tomic V, Marti AT, Stammet P, Brun-Buisson C, Bonten MJ, MOSAR WP3 Study Team. 2014. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14:31-39. http://dx.doi.org/10.1016/S1473-3099(13)70295-0.